Our bones are designed to remodel themselves; this is a lifelong process involving the bones adjusting to maintain strength, repair damages, and react to specific stress'.
Rachael Lee, Acting Programme Manager of the National Wound Care Strategy Programme (NWCSP), discusses the challenges in wound care provision and the efforts to...
A new treatment, Sotatercept, for pulmonary arterial hypertension (PAH) has recently been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA).
Tarlatamaba, a new treatment for adult patients with small cell lung cancer (SCLC), has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA).
Infections are the second leading cause of death in cancer patients, after the cancer itself; Zisis Kozlakidis and Shalini Jayasekar Zurn discuss the challenges surrounding the interplay between cancer and antimicrobial resistance (AMR).
Inflammatory skin diseases like psoriasis involve interactions between skin cells (keratinocytes) and immune cells, which leads to chronic inflammation, disfiguring skin lesions, and systemic effects.
A substantial investment totalling £55 million, made possible through funding from the Northern Ireland Executive alongside various consortium partners, is set to advance innovation within the critical field of precision medicine.
The NHS in England has introduced a new therapy that hopes to transform the lives of hundreds of adults living with X-linked Hypophosphatemia (XLH), this rare genetic disorder causes severe bone, dental, and skeletal issues.
Recent Phase 3 trial results for icotrokinra (JNJ-2113), an investigational oral peptide from Johnson & Johnson, have shown the drug’s potential to offer significant relief for patients suffering from moderate-to-severe plaque psoriasis.
The NHS is looking for volunteers as part of the three cancer projects that have been selected as part of the NHS DigiTrials initiative. Almost 150,000 volunteers will take part in these trials to help transform cancer treatment.
A recent study, published in the journal Nature looked into the six-month impact of switching neovascular age-related macular degeneration and diabetic macular oedema patients to faricimab instead of anti-VEGF therapy.
Lorna Rothery spoke to Dr Cathy Price, Associate Professor in Pain Management and Vice President of the British Pain Society, about the difficulties in diagnosing, treating, and managing chronic pain.
Lorna Rothery interviewed Dr Lauren Sorce, PhD, RN, CPNP-AC/PC, FCCM, President of the Society of Critical Care Medicine and Co-chair of the Surviving Sepsis Campaign, to discuss the challenges of diagnosing and treating sepsis.
